9 | Radioisotopes (Radionuclides)IBA
01/2022
-
01/2019 |
4 | RadiopharmaceuticalsIBA
02/2024
-
12/2018 |
3 | Immune Checkpoint InhibitorsIBA
01/2021
-
01/2021 |
3 | Monoclonal AntibodiesIBA
01/2021
-
01/2018 |
2 | Peptides (Polypeptides)IBA
03/2024
-
12/2022 |
2 | IsotopesIBA
03/2024
-
01/2018 |
2 | Neurotensin Receptors (Neurotensin Receptor)IBA
03/2023
-
12/2022 |
2 | CytokinesIBA
01/2021
-
01/2021 |
1 | Proto-Oncogene Proteins c-metIBA
03/2024 |
1 | Single-Domain AntibodiesIBA
03/2024 |
1 | SiderophoresIBA
03/2024 |
1 | AntigensIBA
03/2024 |
1 | EnterobactinIBA
03/2024 |
1 | Cobalt-55IBA
10/2023 |
1 | Photosensitizing Agents (Photosensitizers)IBA
08/2023 |
1 | PolymersIBA
08/2023 |
1 | NeurotensinIBA
03/2023 |
1 | 1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA
03/2023 |
1 | lysylprolineIBA
03/2023 |
1 | Poly(ADP-ribose) Polymerase InhibitorsIBA
01/2023 |
1 | Staphylococcal Protein A (Protein A)IBA
12/2021 |
1 | Biomarkers (Surrogate Marker)IBA
12/2021 |
1 | Interleukin-13IBA
01/2021 |
1 | InterferonsIBA
01/2021 |
1 | Interleukin-2 (IL2)IBA
01/2021 |
1 | Yttrium-86IBA
01/2021 |
1 | lorukafusp alfaIBA
01/2021 |
1 | Silicon Dioxide (Silica)FDA LinkGeneric
01/2021 |
1 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
01/2021 |
1 | Interleukin-10 (Interleukin 10)IBA
01/2021 |
1 | ChemokinesIBA
01/2021 |
1 | Chelating AgentsIBA
01/2020 |
1 | Excipients (Suspending Agents)IBA
01/2020 |
1 | Thromboplastin (Tissue Factor)IBA
01/2020 |
1 | carotuximabIBA
01/2018 |